The Establishment Inspection Report (EIR) issued to Zydus Lifesciences by the U.S. Food and Drug Administration (USFDA) concerning the GMP follow-up inspection at its injectable manufacturing facility in Jarod, Vadodara. This audit was carried out be
.jpeg "Granules Consumer Health Clears USFDA Inspection with Zero Observation")
Granules India reported that its subsidiary in the U.S., with step-down operations, Granules Consumer Health, LLC, has passed a Good Manufacturing Practice (GMP) inspection conducted by the U.S. Food and Drug Administration (FDA) with zero observatio
Sanofi has completed the acquisition of Vicebio Ltd, and this will make it stronger in the vaccine portfolio and prove its role as an innovative biopharma leader. The acquisition combines an exciting early-stage combination vaccine against...
Astrazeneca's presence at the 2025 ASH Annual Meeting is the largest sharpe in the history of ASH and represents Astrazeneca's continuing efforts to lead the way in haematology. The company's 65 abstracts represent an impressive milestone across...
Global pharma leader Lupin has taken a major step forward in the U.S. biosimilar market with a new exclusive licensing agreement for Armlupeg (pegfilgrastim-unne). The company announced today that it has partnered with Valorum Biologics, a...
Pharma company Corona Remedies, supported by private equity firm ChrysCapital, has set a price range of Rs 1,008-1,062 per share for its forthcoming Initial Public Offering (IPO), which values the firm at approximately Rs 6,500 crore
AptarGroup, a worldwide leader in dosing, dispensing, and protection technologies for drugs and consumer products, has revealed the purchase of Sommaplast, a Brazil-based company that specializes in oral dosing pharmaceutical packaging solutions
Tata 1mg and OneBanc have forged a strategic partnership aimed at revolutionizing India’s corporate healthcare sector, a market valued at over Rs. 12,000 crore annually across diagnostics, outpatient services, and preventive wellness
.png "Cipla Steps Into Regenerative Medicine With Ciplostem Knee OA Therapy")
Ciplostem, launched today by Cipla in partnership with Stempeutics Research, signals a strong move into orthobiologic medicine. The new MSC therapy enters the market as India faces a fast-growing burden of knee osteoarthritis, now affecting more...
.png "Novo Nordisk Brings Ozempic to India to Challenge Mounjaro's Lead")
Danish drugmaker Novo Nordisk is preparing to launch Ozempic in India this month, marking a major move in a market already battling rising diabetes and obesity. The arrival of the blockbuster drug comes at a time when India has the world’s...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")